Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Caspase-7 has functions in skin and hair that are not related to cell death.

A new engineered treatment shows promise in curing heart fibrosis.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Blocking YAP/TAZ could be a new way to treat skin cancer.

WNT5A contributes to keloid scars by promoting cell changes through specific signaling pathways.

Immune cells boost stem cell activity in hairy moles, causing more hair growth.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Early diagnosis and treatment of frontal fibrosing alopecia are crucial to prevent permanent hair loss.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

Smad2/3-dependent TGF-β signaling increases during wound healing.

Blocking the Mitochondrial Pyruvate Carrier causes stress in hair follicles, which can be reduced by an ISR inhibitor.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

YAP1 helps fat cell formation by influencing the Hippo pathway.

JAM-A modification speeds up skin wound healing by boosting fibroblast growth.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

Turning scar-forming cells into fat cells can reduce scarring.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Epidermal growth factor helps hair stem cells grow by activating specific cell pathways.